The efficacy and safety of inhaled salmeterol 50 μg bd in older patients with reversible airflow obstruction

Age and Ageing

Volumn 25, Issue 1, 1996, Pages 67-71

  Starke, I D ^a   Luce, P ^a  

^a Hither Green Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SALMETEROL;

ADULT; ADVERSE DRUG REACTION; AGED; AIRWAY OBSTRUCTION; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MALE; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; ALBUTEROL; BRONCHODILATOR AGENTS; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0030048349     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/25.1.67     Document Type: Article

References (20)

1. 2-adrenoceptor agonist; characterisation of pharmacological activity in vitro and in vivo, Br J Pharmacol 1991;104:665-71.
2. Machonochie JG, Forster JK, Fowler P, et al. An initial comparison of salmeterol and salbutamol against histamine-induced bronchoconstrietion in healthy subjects. Br J Clin Pharmacol 1988;25:115P.
3. Britton MG, Earnshaw JS, Palmer JBD. A twelve-month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992;5:1062-7.
4. Lundback B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 1993;48:148-53.
5. Pearlman DS, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild to moderate asthma. N Engl J Med 1992;327:1420-5.
6. Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium bromide and salbutamol in asthma. Thorax 1981;36:523-9.
7. Vestal RE, Wood AJJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979;26:182-6.
8. Grizzle JE. The two-period change-over design and its use in clinical trials. Biometrics 1965;21:467-80.
9. Armitage P, Hills M. The two-period cross-over trial. Statistician 1982;31:119-31.
10. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 1972;28:577-844.
11. Prescott RS. The comparison of success rates in cross-over trials with a binary response. Appl Stat 1981;34:9-15.
12. Burr ML, Charles TJ, Roy K, et al. Asthma in the elderly: an epidemiological survey. Br Med J 1979;1:1041-4.
13. Weiss ST, Speizer PE. The epidemiology of asthma: risk factors and natural history. In: Weiss FB, Segal MSS, Stein M, eds. Bronchial asthma. Boston: Little, Brown, 1985;14-23.
14. Ford RM. Aetiology of asthma: a review of 11,551 cases. Med J Aust 1969;1:628-31.
15. Horsely JR, Sterling IJN, Waters WE, Howell JBL. Respiratory symptoms among elderly people in the New Forest area as assessed by postal questionnaire. Age Ageing 1991;20:325-31.
16. Dow L, Holgate ST. Assessment and treatment of obstructive airways disease in the elderly. Br Med Bull 1990;46:230-45.
17. Fowler RW, Pluck RA, Hetzel MR. Maximal expiratory flow-volume curves in Londoners aged 60 years and over. Thorax 1987;42:173-82.
18. Braman SS, Kaemmerlen JT, Davis SM. Asthma in the elderly: a comparison between patients with recently acquired and long-standing disease. Am Rev Resp Dis 1991;143:336-40.
19. Connolly MJ, Crowley JJ, Charan MB, Nielson CP, Vestal RE. Reduced subjective awareness of broncho-constriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax 1992;47:410-13.
20. Dawe CN, Cheesman MG, Pounsford JC. Salmeterol is an effective bronchodilator in elderly patients. Eur Respir J 1992;5(suppl 15):204s.